The clinical nutrition for cancer care market has seen considerable growth due to a variety of factors.
• The clinical nutrition for cancer care market has grown significantly in recent years. It is projected to increase from $4.92 billion in 2024 to $5.22 billion in 2025, at a compound annual growth rate (CAGR) of 5.9%.
The growth is driven by greater awareness of nutritional needs, the emergence of precision nutrition, changes in healthcare policies and reimbursement models, cancer-related surgical interventions, and the growing interest in functional foods and dietary supplements.
The clinical nutrition for cancer care market is expected to maintain its strong growth trajectory in upcoming years.
• The clinical nutrition for cancer care market is expected to grow to $6.48 billion by 2029 at a 5.6% CAGR. The growth is driven by personalized medicine, increasing awareness of nutrition's role in cancer treatment, and advancing cancer treatments. Trends include research in nutritional biomarkers, innovations in delivery systems, and collaboration between oncologists.
The rising prevalence of cancer is expected to propel the clinical nutrition for cancer care market. As cancer rates increase with longer life expectancies, clinical nutrition plays a crucial role in supporting cancer patients’ nutritional needs. The World Health Organization predicts that cancer cases will rise to 35 million by 2050, a 77% increase from 2022.
The clinical nutrition for cancer care market covered in this report is segmented –
1) By Type: Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas
2) By Cancer Type: Head And Neck Cancer, Stomach And Gastrointestinal Cancers, Blood Cancer, Breast Cancer, Lung Cancer, Other Cancer Types
3) By Age Group: Adult, Pediatric
4) By Sales Channel: Online, Retail, Institutional Sales
Subsegments:
1) By Oral Nutrition: Protein-Rich Supplements, Carbohydrate-Rich Supplements, Fat-Rich Supplements, Vitamins And Mineral Supplements, Caloric Supplements, Fiber-Enriched Supplements
2) By Parenteral Nutrition: Amino Acids, Carbohydrates, Lipids, Electrolytes And Micronutrients, Intravenous Fat Emulsions, Trace Elements And Vitamins
3) By Enteral Feeding Formulas: Standard Enteral Feeding Formulas, High-Protein Enteral Formulas, High-Calorie Enteral Formulas, Diabetic Enteral Formulas, Elemental Enteral Formulas, Specialized Enteral Formulas
Companies in the clinical nutrition for cancer care market are introducing products like oral nutritional supplements to support cancer patients. In July 2022, Nestle launched Oral Impact Su Yi Su in China, a supplement designed for patients undergoing cancer treatment. This supplement contains essential nutrients like arginine and omega-3 to help meet the nutritional needs of patients with tumor-related conditions.
Major companies operating in the clinical nutrition for cancer care market are:
• Pfizer Inc.
• Bayer AG
• Abbott Nutrition
• GlaxoSmithKline plc
• Reckitt Benckiser Group plc
• Evonik Industries AG
• Baxter International Inc.
• Otsuka Holdings Co. Ltd.
• B. Braun Melsungen AG
• Koninklijke DSM N.V.
• Glanbia plc
• Kyowa Kirin Co. Ltd
• Nestle Health Science S.A.
• Danone Nutricia
• BioGaia AB
• Meiji Holdings Company Ltd.
• Hormel Health Labs
• Victus Inc.
• Taiho Pharmaceutical Co. Ltd.
• Global Health Products Inc
North America was the largest region in the clinical nutrition for cancer care market in 2023. The regions covered in the clinical nutrition for cancer care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.